These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35713618)

  • 1. Assessment of the Stability of Midregional Proadrenomedullin in Different Biological Matrices.
    Angeletti S; Legramante JM; Lia MS; D'Amico L; Fogolari M; Cella E; De Cesaris M; De Angelis F; Pieri M; Terrinoni A; Bernardini S; Minieri M
    Lab Med; 2023 Jan; 54(1):41-46. PubMed ID: 35713618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
    Morgenthaler NG; Struck J; Alonso C; Bergmann A
    Clin Chem; 2005 Oct; 51(10):1823-9. PubMed ID: 16099941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma midregional proadrenomedullin (MR-proADM) concentrations and their biological determinants in a reference population.
    Krintus M; Kozinski M; Braga F; Kubica J; Sypniewska G; Panteghini M
    Clin Chem Lab Med; 2018 Jun; 56(7):1161-1168. PubMed ID: 29432202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis.
    Bernal-Morell E; García-Villalba E; Vera MDC; Medina B; Martinez M; Callejo V; Valero S; Cinesi C; Piñera P; Alcaraz A; Marin I; Muñoz A; Cano A
    J Infect; 2018 Mar; 76(3):249-257. PubMed ID: 29246637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.
    Huang DT; Angus DC; Kellum JA; Pugh NA; Weissfeld LA; Struck J; Delude RL; Rosengart MR; Yealy DM
    Chest; 2009 Sep; 136(3):823-831. PubMed ID: 19363212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19.
    Lo Sasso B; Gambino CM; Scichilone N; Giglio RV; Bivona G; Scazzone C; Muratore R; Milano S; Barbagallo M; Agnello L; Ciaccio M
    Lab Med; 2021 Sep; 52(5):493-498. PubMed ID: 33928380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midregional proadrenomedullin safely reduces hospitalization in a low severity cohort with infections in the ED: a randomized controlled multi-centre interventional pilot study.
    Gonzalez Del Castillo J; Clemente-Callejo C; Llopis F; Irimia A; Oltra-Hostalet F; Rechner C; Schwabe A; Fernandez-Rodriguez V; Sánchez-Mora C; Giol-Amich J; Prieto-García B; Bardés-Robles I; Ortega-de Heredia MD; García-Lamberechts EJ; Navarro-Bustos C;
    Eur J Intern Med; 2021 Jun; 88():104-113. PubMed ID: 33906810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proadrenomedullin in Sepsis and Septic Shock: A Role in the Emergency Department.
    Piccioni A; Saviano A; Cicchinelli S; Valletta F; Santoro MC; de Cunzo T; Zanza C; Longhitano Y; Tullo G; Tilli P; Candelli M; Covino M; Franceschi F
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis.
    Palladini G; Barassi A; Perlini S; Milani P; Foli A; Russo P; Albertini R; Obici L; Lavatelli F; Sarais G; Casarini S; Moratti R; Melzi d'Eril GV; Merlini G
    Amyloid; 2011 Dec; 18(4):216-21. PubMed ID: 22070520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midregional proadrenomedullin for prognosis in community-acquired pneumonia: a systematic review.
    Cavallazzi R; El-Kersh K; Abu-Atherah E; Singh S; Loke YK; Wiemken T; Ramirez J
    Respir Med; 2014 Nov; 108(11):1569-80. PubMed ID: 25448309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
    Morbach C; Marx A; Kaspar M; Güder G; Brenner S; Feldmann C; Störk S; Vollert JO; Ertl G; Angermann CE;
    Eur J Heart Fail; 2017 Sep; 19(9):1166-1175. PubMed ID: 28516504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.
    Gordo-Remartínez S; Calderón-Moreno M; Fernández-Herranz J; Castuera-Gil A; Gallego-Alonso-Colmenares M; Puertas-López C; Nuevo-González JA; Sánchez-Sendín D; García-Gámiz M; Sevillano-Fernández JA; Álvarez-Sala LA; Andueza-Lillo JA; de Miguel-Yanes JM
    PLoS One; 2015; 10(6):e0125212. PubMed ID: 26030588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR-Proadrenomedullin as biomarker of renal damage in urinary tract infection in children.
    Peñalver Penedo R; Rupérez Lucas M; Álvarez-Sala Walther LA; Torregrosa Benavent A; Casas Losada ML; Bañuelos Andrio L; Rebolledo Poves AB; Bueno Campaña M
    BMC Pediatr; 2021 Jun; 21(1):292. PubMed ID: 34187408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study.
    Wild PS; Schnabel RB; Lubos E; Zeller T; Sinning CR; Keller T; Tzikas S; Lackner KJ; Peetz D; Rupprecht HJ; Bickel C; Morgenthaler NG; Papassotiriou J; Tiret L; Münzel T; Blankenberg S
    Clin Chem; 2012 Jan; 58(1):226-36. PubMed ID: 22065157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study.
    Funke-Kaiser A; Mann K; Colquhoun D; Zeller T; Hunt D; Simes J; Sullivan D; Sydow K; West M; White H; Blankenberg S; Tonkin AM;
    Int J Cardiol; 2014 Mar; 172(2):411-8. PubMed ID: 24508492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30).
    Landman GW; van Dijk PR; Drion I; van Hateren KJ; Struck J; Groenier KH; Gans RO; Bilo HJ; Bakker SJ; Kleefstra N
    Diabetes Care; 2014; 37(3):839-45. PubMed ID: 24170764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
    Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
    Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of adrenomedullin in eutopic endometrium and plasma from women with endometriosis.
    Matson BC; Quinn KE; Lessey BA; Young SL; Caron KM
    Fertil Steril; 2018 Jun; 109(6):1072-1078. PubMed ID: 29871794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
    Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
    Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.
    Neumann JT; Tzikas S; Funke-Kaiser A; Wilde S; Appelbaum S; Keller T; Ojeda-Echevarria F; Zeller T; Zwiener I; Sinning CR; Jagodzinski A; Schnabel RB; Lackner KJ; Münzel T; Blankenberg S; Wild PS; Sydow K
    Atherosclerosis; 2013 Jun; 228(2):451-9. PubMed ID: 23562132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.